Clinical Trial

Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease

Study acronym: FRESH-CSVD
Recruiting
View on ClinicalTrials.gov →
Summary
Cerebral small-vessel disease (CSVD) is a significant contributor to stroke and dementia, primarily impacting individuals over the age of 60. Its prevalence exceeds 70% in the elderly population, imposing a substantial burden on brain health and the economy. Optical coherence tomography angiography (OCTA) is a new type of optical diagnostic imaging technology for non-invasive detection, which can perform multi-dimensional quantitative assessment of fundus retinopathy. Current studies have shown that fundus OCTA-derived parameters may have potential in characterizing imaging changes in CSVD. However, the correlation between retinal/choroidal parameters on OCTA and the CSVD imaging markers remains uncertain. FRESH-CSVD is a prospective, observational study that will use fundus OCTA-derived parameters to screen patients with CSVD, explore the relationship between relevant parameters based on OCTA measurements and CSVD, and evaluate the feasibility and clinical value of identification of CSVD through fundus OCTA.
Trial Details
NCT Number NCT06431711
Lead Sponsor Zhejiang Provincial People's Hospital
Conditions Cerebral Small Vessel Diseases, Retinal Ischemia, Choroid; Injury
Enrollment 2,400 participants
Start Date 2024-04-01
Primary Completion 2029-03-31 (estimated)
Study Completion 2034-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-29